Brian Johnson, former head of R&D technology at Takeda, now consultant, shares his unique perspective on a topic that’s top-of-mind for many: how do you introduce new technologies and processes without alienating the people who need them most? He and Manny also tackle the critical issue of health equity, examining how technology can help diversify clinical trials and, in turn, create a more equitable future for all. Join us as we explore the business case for change and the crucial steps needed to unstick the industry from its current trajectory. Subscribe to Unblinded, a Clinical Trial podcast, to get new episodes as soon as they are released. Spotify: https://visit.veeva.com/93z Apple Podcasts: https://visit.veeva.com/lrx Veeva website: https://www.veeva.com/unblindedpod/

 18      0